These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19821798)

  • 1. Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system.
    Court MH
    Drug Metab Rev; 2010 Feb; 42(1):209-24. PubMed ID: 19821798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of Human Hepatic Uridine Diphosphate Glucuronosyltransferase Proteins: Implications for Ontogenetic Mechanisms and Isoform Coregulation.
    Liu Y; Badée J; Takahashi RH; Schmidt S; Parrott N; Fowler S; Mackenzie PI; Coughtrie MWH; Collier AC
    J Clin Pharmacol; 2020 Jun; 60(6):722-733. PubMed ID: 31879975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers.
    Yasar U; Greenblatt DJ; Guillemette C; Court MH
    J Pharm Pharmacol; 2013 Jun; 65(6):874-83. PubMed ID: 23647681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.
    Court MH; Freytsis M; Wang X; Peter I; Guillemette C; Hazarika S; Duan SX; Greenblatt DJ; Lee WM;
    J Pharmacol Exp Ther; 2013 May; 345(2):297-307. PubMed ID: 23408116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.
    Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S
    Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes: Comparison of Two Proteomic Methods and Correlation with Catalytic Activity.
    Achour B; Dantonio A; Niosi M; Novak JJ; Fallon JK; Barber J; Smith PC; Rostami-Hodjegan A; Goosen TC
    Drug Metab Dispos; 2017 Oct; 45(10):1102-1112. PubMed ID: 28768682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Ontogeny of Hepatic UDP-Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes.
    Badée J; Qiu N; Collier AC; Takahashi RH; Forrest WF; Parrott N; Schmidt S; Fowler S
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S42-S55. PubMed ID: 31502688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin.
    Fujiwara R; Sumida K; Kutsuno Y; Sakamoto M; Itoh T
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):82-8. PubMed ID: 25760534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
    Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
    Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig.
    Higashi E; Ando A; Iwano S; Murayama N; Yamazaki H; Miyamoto Y
    Biopharm Drug Dispos; 2014 Sep; 35(6):313-20. PubMed ID: 24752421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen.
    Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Swedmark S; Miners JO
    Br J Clin Pharmacol; 2005 Oct; 60(4):423-33. PubMed ID: 16187975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes.
    Kuehl GE; Bigler J; Potter JD; Lampe JW
    Drug Metab Dispos; 2006 Feb; 34(2):199-202. PubMed ID: 16258079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels.
    Bock KW
    Biochem Pharmacol; 2010 Sep; 80(6):771-7. PubMed ID: 20457141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver.
    Court MH; Hao Q; Krishnaswamy S; Bekaii-Saab T; Al-Rohaimi A; von Moltke LL; Greenblatt DJ
    J Pharmacol Exp Ther; 2004 Aug; 310(2):656-65. PubMed ID: 15044558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.
    Fisher MB; Vandenbranden M; Findlay K; Burchell B; Thummel KE; Hall SD; Wrighton SA
    Pharmacogenetics; 2000 Nov; 10(8):727-39. PubMed ID: 11186135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes.
    Rouguieg K; Picard N; Sauvage FL; Gaulier JM; Marquet P
    Drug Metab Dispos; 2010 Jan; 38(1):40-5. PubMed ID: 19841060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Industrial Approach to Determine the Relative Contribution of Seven Major UGT Isoforms to Hepatic Glucuronidation.
    Busse D; Leandersson S; Amberntsson S; Darnell M; Hilgendorf C
    J Pharm Sci; 2020 Jul; 109(7):2309-2320. PubMed ID: 32294459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UDP-glucuronosyltransferase 2B15 (UGT2B15) is the major enzyme responsible for sipoglitazar glucuronidation in humans: retrospective identification of the UGT isoform by in vitro analysis and the effect of UGT2B15*2 mutation.
    Nishihara M; Hiura Y; Kawaguchi N; Takahashi J; Asahi S
    Drug Metab Pharmacokinet; 2013; 28(6):475-84. PubMed ID: 23648677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone.
    Nishiyama T; Kobori T; Arai K; Ogura K; Ohnuma T; Ishii K; Hayashi K; Hiratsuka A
    Arch Biochem Biophys; 2006 Oct; 454(1):72-9. PubMed ID: 16949544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes.
    Kuehl GE; Lampe JW; Potter JD; Bigler J
    Drug Metab Dispos; 2005 Jul; 33(7):1027-35. PubMed ID: 15843492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.